Concepedia

Laura Seclì

LS

Statistics

Publications

4

Citations

151

H-Index

4

Active since

2017

Affiliations

University of Turin(Current)

University of Naples Federico II

Nouscom (Italy)

Laura Seclì is an author at University of Turin specializing in metastatic signaling pathways, cancer cell signaling, and oncology.

ORCID

Publications per year

2017–2024

4

Publications

4

The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis

Federica Fusella, Laura Seclì, Elena Busso et al. · Nature Communications · 2017 · 90 citations · Full text

, , +17

Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

Laura Seclì, Lidia Avalle, Pietro Poggio et al. · Cancer Research · 2021 · 38 citations · Full text

, , +17

Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine

Irene Garzia, Linda Nocchi, Lidia Avalle et al. · Cancer Immunology Research · 2024 · 12 citations · Full text

, , +17

Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer

Anna Morena D’Alise, Linda Nocchi, Irene Garzia et al. · Frontiers in Immunology · 2023 · 11 citations · Full text

, , +17

1–4 of 4